Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/1170
Title: | Clinical outcomes of transcatheter aortic valve implantation in nonagenarians. |
Epworth Authors: | Dick, Ronald Duffy, Stephen Stub, Dion Walton, Anthony Larobina, Marco Marasco, Silvana |
Other Authors: | Leary, Olivia Zamani, Jalal Johnston, R. Holland, S. |
Keywords: | Aortic Valve Replacement AVR Transcatheter Aortic Valve Implantation TAVI Surgical Aortic Valve Replacement SAVR Nonagenarians Elderly Patients Intermediate Risk Patients Aortic Stenosis High Risk Patients Society of Thoracic Surgeons Score STS Clinical Frailty Score CFS 30-Day Mortality And Stroke One Through To Six Year Survival 1 Through To 6 Year Survival Clinical Outcomes Victorian Heart Centre, Epworth HealthCare, Richmond, Victoria, Australia Cardiac Sciences Clinical Institute, Epworth HealthCare, Victoria, Australia |
Issue Date: | Jun-2017 |
Citation: | Epworth Research Institute Research Week 2017; Poster 21: pp 44-45 |
Conference Name: | Epworth Research Institute Research Week 2017 |
Conference Location: | Epworth Research Institute, Victoria, Australia |
Abstract: | BACKGROUND: Surgical Aortic Valve Replacement (SAVR) has been the gold standard for managmement of aortic stenosis until Transcatheter Aortic Valve Implementation (TAVI) emerged. TAVI is an alternative treatment option for intermediate and high risk patients. The aim of this research was to evaluate the clinical outcomes of the ≥90 years patient group compared with the <90 years patient group who have had TAVI at Epworth HealthCare and Alfred Hospital. METHODS: Data were prospectively collected from August 2008 to April 2017 on 559 patients. Data were divided into two groups, ≥90 and <90 year old. Data points included: Society of Thoracic Surgeons (STS) score, clinical frailty score (CFS), 30-day mortality and stroke, and one through to 6 year survival. RESULTS: Of 559 patients, 66 (33%) were nonagenarians. CFS of 3.9 (range 1-9). Average NYHA at discharge 1 (range 1-4). [See table on poster]. CONCLUSIONS: TAVI has become the preferred method of AVR in the elderly population. Our data suggest that TAVI can be undertaken safely in very elderly patients with good survival. Therefore, patients should not be excluded based on age alone. Careful work up in selected patients remains integral to optimal outcomes. |
URI: | http://hdl.handle.net/11434/1170 |
Type: | Conference Poster |
Affiliated Organisations: | Alfred Hospital |
Type of Clinical Study or Trial: | Prospective Study |
Appears in Collections: | Cardiac Sciences Research Week |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.